Drug intelligence / Profile preview

AFFIRM

Development stage
Unknown
Lead developer
AFFIRM Science
Modality
Small Molecules
Administration
Oral
01

Overview

AFFIRM is a nitric oxide-boosting nutraceutical developed by Dr. Judson Brandeis and marketed through AFFIRM Science and Brandeis MD. It is specifically formulated to support erectile function and cardiovascular health by enhancing the nitric oxide pathway. The supplement contains a combination of pharmaceutical-grade active ingredients, including L-citrulline, red beet root extract, Panax ginseng, and Muira puama. By increasing nitric oxide production, AFFIRM promotes vasodilation and improves blood flow to penile tissues. Clinical research, including the CONfirm studies, has demonstrated that the supplement can increase the intensity and duration of nighttime erectile activity by approximately 33% in men with mild erectile dysfunction. It is frequently used as an adjunct to shockwave therapy for erectile dysfunction and is also indicated for improving energy and athletic performance.

Brand names
AFFIRM
Other names
AFFIRM Nitric Oxide BoosterBrandeis MD AFFIRM
02

Targets

NO2- (Nitrite)

Beyond the preview

Go deeper on AFFIRM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AFFIRM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call